bicalutamide has been researched along with calcitriol in 13 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (7.69) | 18.2507 |
| 2000's | 7 (53.85) | 29.6817 |
| 2010's | 5 (38.46) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Hashimoto, Y; Makishima, M; Nakamura, M | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Feldman, D; Ly, LH; Peehl, DM; Zhao, XY | 1 |
| Feldman, D; Navone, NM; Peehl, DM; Zhao, XY | 1 |
| Lou, YR; Nazarova, N; Pennanen, P; Qiao, S; Tuohimaa, P | 1 |
| Bao, BY; Hu, YC; Lee, YF; Ting, HJ | 1 |
| Lou, YR; Nazarova, N; Talonpoika, R; Tuohimaa, P | 1 |
| Agoulnik, IU; Murthy, S; Weigel, NL | 1 |
| Bisoffi, M; Ji, M; Omdahl, JL; Serda, RE; Sillerud, LO; Thompson, TA | 1 |
| Washington, MN; Weigel, NL | 1 |
1 review(s) available for bicalutamide and calcitriol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
12 other study(ies) available for bicalutamide and calcitriol
| Article | Year |
|---|---|
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Development of silicon-containing bis-phenol derivatives as androgen receptor antagonists: selectivity switching by C/Si exchange.
Topics: Androgen Receptor Antagonists; Cell Line, Tumor; Cell Proliferation; HEK293 Cells; Humans; Phenol; Receptors, Androgen; Receptors, Calcitriol; Silicon | 2013 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
1alpha,25-dihydroxyvitamin D3 actions in LNCaP human prostate cancer cells are androgen-dependent.
Topics: Analysis of Variance; Androgen Antagonists; Androgens; Anilides; Blotting, Northern; Blotting, Western; Calcitriol; Cell Division; Dihydrotestosterone; Dose-Response Relationship, Drug; Drug Synergism; Humans; Male; Neoplasms, Hormone-Dependent; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Tosyl Compounds; Tritium; Tumor Cells, Cultured; Up-Regulation | 1997 |
1alpha,25-dihydroxyvitamin D3 inhibits prostate cancer cell growth by androgen-dependent and androgen-independent mechanisms.
Topics: Androgen Antagonists; Androgens; Anilides; Antineoplastic Agents; Cell Division; Humans; Ligands; Male; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; Receptors, Calcitriol; Tosyl Compounds; Up-Regulation; Vitamin D | 2000 |
Inhibition of fatty acid synthase expression by 1alpha,25-dihydroxyvitamin D3 in prostate cancer cells.
Topics: Androgen Antagonists; Anilides; Calcitriol; Cerulenin; Cycloheximide; Down-Regulation; Enzyme Inhibitors; Fatty Acid Synthases; Flutamide; Gene Expression Regulation, Neoplastic; Humans; Male; Nitriles; Oligonucleotide Array Sequence Analysis; Prostatic Neoplasms; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tosyl Compounds; Tumor Cells, Cultured | 2003 |
Androgen signaling is required for the vitamin D-mediated growth inhibition in human prostate cancer cells.
Topics: Androgens; Anilides; Calcitriol; Cell Line, Tumor; Humans; Male; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Receptors, Calcitriol; RNA Interference; Signal Transduction; Tosyl Compounds | 2004 |
5alpha-dihydrotestosterone inhibits 1alpha,25-dihydroxyvitamin D3-induced expression of CYP24 in human prostate cancer cells.
Topics: Androgen Receptor Antagonists; Androgens; Anilides; Calcitriol; Cycloheximide; Cytochrome P-450 Enzyme System; Dihydrotestosterone; Drug Interactions; Flutamide; Gene Expression Regulation, Enzymologic; Humans; Male; Nitriles; Prostatic Neoplasms; Protein Synthesis Inhibitors; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Signal Transduction; Steroid Hydroxylases; Tosyl Compounds; Tumor Cells, Cultured; Vitamin D3 24-Hydroxylase | 2005 |
Androgen receptor signaling and vitamin D receptor action in prostate cancer cells.
Topics: Androgen Antagonists; Anilides; Apoptosis; Calcitriol; Calcium Channel Agonists; Cell Division; DNA-Binding Proteins; Drug Interactions; Humans; Male; Nitriles; Prostatic Neoplasms; Receptors, Androgen; Receptors, Calcitriol; Signal Transduction; Tosyl Compounds; Transcription Factors; Tumor Cells, Cultured | 2005 |
1alpha,25-Dihydroxyvitamin D3 down-regulates expression of prostate specific membrane antigen in prostate cancer cells.
Topics: Androgen Antagonists; Anilides; Antineoplastic Agents; Biomarkers, Tumor; Calcitriol; Cell Line, Tumor; Cell Proliferation; Dose-Response Relationship, Drug; Down-Regulation; Drug Screening Assays, Antitumor; Gene Silencing; Humans; Male; Membrane Proteins; Nitriles; Prostate-Specific Antigen; Prostatic Neoplasms; Receptors, Androgen; RNA, Small Interfering; Tosyl Compounds | 2008 |
1{alpha},25-Dihydroxyvitamin D3 inhibits growth of VCaP prostate cancer cells despite inducing the growth-promoting TMPRSS2:ERG gene fusion.
Topics: Analysis of Variance; Androgen Antagonists; Anilides; Blotting, Western; Calcitriol; Cell Count; Cell Line; Cell Proliferation; Cells, Cultured; Dose-Response Relationship, Drug; Gene Expression; Humans; Nitriles; Oncogene Fusion; Oncogene Proteins, Fusion; Receptors, Androgen; Receptors, Calcitriol; Reverse Transcriptase Polymerase Chain Reaction; Tosyl Compounds; Trans-Activators; Transcriptional Regulator ERG; Vitamins | 2010 |